Altered gene expression in squamous cell carcinoma arising from congenital unilateral linear porokeratosis

Clinical and Experimental Dermatology

Volumn 37, Issue 7, 2012, Pages 781-785

  Scola, Nina ^a   Skrygan, M ^a   Wieland, U ^b   Kreuter, A ^a   Gambichler, T ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ETRETIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INVOLUCRIN; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN P53; PSORIASIN; UVOMORULIN; VIRUS DNA;

ACTINIC KERATOSIS; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SURGERY; CASE REPORT; CONGENITAL UNILATERAL LINEAR POROKERATOSIS; DNA ISOLATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPULE; POLYMERASE CHAIN REACTION; POROKERATOSIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; HUMANS; NEOPLASM PROTEINS; POROKERATOSIS; PSORIASIS; RNA, MESSENGER; SKIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84866641965     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04393.x     Document Type: Article

References (10)

1. Hivnor C, Williams N, Singh F, et al. Gene expression profiling of porokeratosis demonstrates similarities with psoriasis. J Cutan Pathol 2004; 31: 657-64.
2. Kreuter A, Jaouhar M, Skrygan M, et al. Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus. J Am Acad Dermatol 2011; 65: 125-33.
3. Gambichler T, Skrygan M, Tomi NS, et al. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008; 147: 17-24.
4. Wieland U, Ritzkowsky A, Stoltidis M, et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000; 115: 124-8.
5. Sasson M, Krain AD,. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 1996; 22: 339-42.
6. Scola N, Gambichler T, Saklaoui H, et al. The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and their precursor lesions. Br J Dermatol (in press).
7. Rayess H, Wang MB, Srivatsan ES,. Cellular senescence and tumor suppressor gene p16. Int J Cancer 2012; 130: 1715-25.
8. Watanabe S, Ichikawa E, Takahashi H, et al. Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy. Br J Dermatol 1995; 132: 730-9.
9. Mastoraki A, Ioannidis E, Apostolaki A, et al. PGP 9.5 and cyclin D1 coexpression in cutaneous squamous cell carcinomas. Int J Surg Pathol 2009; 17: 413-20.
10. Black AP, Ogg GS,. The role of p53 in the immunobiology of cutaneous squamous cell carcinoma. Clin Exp Immunol 2003; 132: 379-84.